Sirolimus-associated pulmonary toxicity

Transplantation

Volumn 77, Issue 8, 2004, Pages 1215-1220

  Pham, Phuong Thu T ^a,c   Pham, Phuong Chi T ^b   Danovitch, Gabriel M ^a   Ross, David J ^a   Gritsch, H Albin ^a   Kendrick, Elizabeth A ^a   Singer, Jennifer ^a   Shah, Tariq ^a   Wilkinson, Alan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BASILIXIMAB; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; LEVOTHYROXINE SODIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CADAVER KIDNEY; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DYSPNEA; FEMALE; GRAFT REJECTION; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HISTOLOGY; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG TOXICITY; LYMPHOCYTIC ALVEOLITIS; MALE; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 2342630498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000118413.92211.B6     Document Type: Article

References (10)

1. Kahan BD, for the Rapamune US Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicentre study. Lancet 2000; 356: 194.
2. McDonald AS, for the Rapamune Global Study Group. A Worlwide, phase III, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271.
3. Mahalati K. Bronchiolitis obliterans and organizing pneumonia in renal transplant recipients. Transplantation 2000; 69: 1531.
4. Singer SJ, Tiernan R, Sullivan EJ. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000; 343: 1815.
5. Morelon E, Stern M, Israel-Biet D, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001; 72: 787.
6. Morelon E, Stern M, Kreis H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000; 343: 225.
7. McWilliams TJ, Levvey BJ, Russell PA, et al. Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation. J Heart Lung Transplant 2003; 22: 210.
8. Lennon A, Finan K, Fitzgerald MX, et al. Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation. Transplantation 2001; 72: 1166.
9. Ravinshankar R, Samuel LE, Kaufman MS, et al. Amiodarone-associated hemoptysis. Am J Med Sci 1998; 316: 390.
10. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 17: 152.